On April 8 2026, Quantum‑Si announced that its first customer samples were successfully tested on the Proteus prototype system, a key step toward the planned end‑2026 launch of the next‑generation protein‑sequencing platform.
The Proteus prototype incorporates Quantum‑Si’s single‑molecule semiconductor detection technology, delivering high‑throughput, amino‑acid‑level sequencing that outperforms existing mass‑spectrometry solutions. The successful testing confirms the system’s ability to handle real‑world samples and demonstrates improved amino‑acid coverage, longer read lengths, and greater sequencing output compared to the Platinum Pro system.
The Proteus platform is central to Quantum‑Si’s future growth strategy. The company has priced the platform at $425,000 and targets a commercial launch at the end of 2026. The milestone supports the company’s roadmap and signals progress toward a product that could reshape proteomics markets.
In Q4 2025, Quantum‑Si reported revenue of $0.45 million and a net loss of $17.6 million. The company guided for 2026 revenue of approximately $1 million, emphasizing a transition year focused on platform development over immediate revenue growth. The guidance reflects the company’s intent to build a customer base and consumable pipeline while managing cash burn.
Jeff Hawkins, President and CEO, said, "Being able to demonstrate that the Proteus prototype system exceeds Platinum performance across all metrics on real world samples is an important milestone in the development of this new platform." He added, "We expect sequencing performance to continue to increase from here as we work to further optimize the Proteus system into our final commercial offering." CFO Jeff Keyes noted, "We view 2026 as a deliberate transition year for the company as we prepare for the anticipated launch of Proteus at the end of 2026, we are making intentional choices that prioritize long‑term platform adoption over near‑term revenue maximization."
Investors have expressed caution following recent revenue misses and high cash burn, but the milestone provides evidence of technological progress that could strengthen the company’s long‑term competitive position.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.